Atellica CH 930 Analyzer, Siemens Material Number 11067000 with software version v1.21.0 SP1 or lower
FDA Recall Z-1797-2020 · Posted None
Advertisement
Recalling FirmSiemens Healthcare Diagnostics, Inc.
Recall StatusTerminated
Product CodeJGS
Date Initiated2020-02-27
Date Terminated2021-10-25
Product Quantity1807
Reason for Recall
Editing an assay Test Definition and switching to another assay s Test Definition screen without saving the changes using the save button on the screen, may corrupt the settings of the assay s test definition, and Auto-Rerun or Auto-Dilution results may generate a result of Zero (0) for quantitative assays or Negative for qualitative assays if a well of the reagent pack is not calibrated.
Firm Action
An Urgent Medical Device Correction notification letter dated 2/27/20 was sent to customers.
The purpose of this communication is to inform you of the issues listed in Table 2 below, that can
occur on the Atellica CH 930 Analyzer, installed with Atellica Solution software (SW) versions
v1.21.0 SP1 or lower and provide instructions on actions your laboratory must take.
These issues will be corrected in SW v1.22.0 and v1.21.11, which will be available soon.
Actions to be Taken by the Customer
The following actions must be taken until your system has been updated to software version
v1.22.0 (or V1.21.11 for Atellica Solution with decapper modules) or higher which resolves the
issues listed above.
1. When making modifications to an assays Test Definition settings on the Setup>Test
Definition>CH Test Definition screen, always follow the instructions outlined in the
Atellica Solution online help 1.20 instructions Editing Assay Identification Parameters
in CH Test Definition. Each Test Definition must be saved using the Save button on
the CH Test Definition screen before starting modifications on another assays Test
Definition. After changing any setting on the Definition, Calculation, or Calibration tabs
of the CH Test Definition screen, select Save and then OK. Verify that QC results are
not affected, and that results, units, and flags are reported correctly for any Test
Definition that has been updated before running patient samples.
2. Ensure all reagent packs have a valid calibration (all wells) before running samples.
This information is available on the screen Calibration > Calibration Overview. Refer to
the Atellica Solution online help 1.20 instructions, Viewing Assay Reagent Calibration
Order Status.
When available, software v1.22.0 and/or v1.21.11 will be delivered as follows:
For systems running software v1.19.0 or higher, that are connected to the Smart
Remote Service (SRS), the software will be delivered electronically
Root Cause
Under Investigation by firm
Distribution Pattern
US Nationwide. Global distribution.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement